BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23216075)

  • 1. Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children.
    Lidehäll AK; Engman ML; Sund F; Malm G; Lewensohn-Fuchs I; Ewald U; Tötterman TH; Karltorp E; Korsgren O; Eriksson BM
    Scand J Immunol; 2013 Feb; 77(2):135-43. PubMed ID: 23216075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of cytomegalovirus-specific cell-mediated immunity in the congenital infection.
    Hayashi N; Kimura H; Morishima T; Tanaka N; Tsurumi T; Kuzushima K
    J Med Virol; 2003 Oct; 71(2):251-8. PubMed ID: 12938200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood.
    Chen SF; Tu WW; Sharp MA; Tongson EC; He XS; Greenberg HB; Holmes TH; Wang Z; Kemble G; Manganello AM; Adler SP; Dekker CL; Lewis DB; Arvin AM
    J Infect Dis; 2004 May; 189(9):1619-27. PubMed ID: 15116298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
    Eid AJ; Brown RA; Hogan WJ; Lahr BD; Eckel-Passow JE; Litzow MR; Razonable RR
    Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
    J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
    Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; Garcia-Noblejas A; Clari MA; Chilet M; López J; Hernández-Boluda JC; Remigia MJ; Navarro D
    J Med Virol; 2010 Jul; 82(7):1208-15. PubMed ID: 20513086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus-specific T cells are detectable in early childhood and allow assignment of the infection status in children with passive maternal antibodies.
    Ritter M; Schmidt T; Dirks J; Hennes P; Juhasz-Böss I; Solomayer EF; Gortner L; Gärtner B; Rohrer T; Sester U; Sester M
    Eur J Immunol; 2013 Apr; 43(4):1099-108. PubMed ID: 23280326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation.
    Guérin V; Dalle JH; Pédron B; Ouachée-Chardin M; Yakouben K; Baruchel A; Sterkers G
    Bone Marrow Transplant; 2010 Mar; 45(3):442-9. PubMed ID: 19633694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
    Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
    Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children.
    Tu W; Chen S; Sharp M; Dekker C; Manganello AM; Tongson EC; Maecker HT; Holmes TH; Wang Z; Kemble G; Adler S; Arvin A; Lewis DB
    J Immunol; 2004 Mar; 172(5):3260-7. PubMed ID: 14978134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Exhaustion Limits CD4+ and CD8+ T-Cell Responses to Congenital Cytomegalovirus Infection.
    Huygens A; Lecomte S; Tackoen M; Olislagers V; Delmarcelle Y; Burny W; Van Rysselberge M; Liesnard C; Larsen M; Appay V; Donner C; Marchant A
    J Infect Dis; 2015 Aug; 212(3):484-94. PubMed ID: 25657256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.
    Maecker HT; Maino VC
    Hum Immunol; 2004 May; 65(5):493-9. PubMed ID: 15172449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT.
    Król L; Stuchlý J; Hubáček P; Keslová P; Sedláček P; Starý J; Hrušák O; Kalina T
    Bone Marrow Transplant; 2011 Aug; 46(8):1089-98. PubMed ID: 21057553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
    Singh KP; Howard JL; Wild SP; Jones SL; Hoy J; Lewin SR
    Clin Immunol; 2007 Aug; 124(2):200-6. PubMed ID: 17574925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.
    Gibson L; Dooley S; Trzmielina S; Somasundaran M; Fisher D; Revello MG; Luzuriaga K
    J Infect Dis; 2007 Jun; 195(12):1789-98. PubMed ID: 17492595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J; Schellens IM; van Baarle D
    Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.